PLx Pharma Inc is US-based biopharmaceutical company which focuses on the development and commercialization of Locilex, which is a novel, topical antibiotic. The Locilex is a chemically synthesized, 22-amino acid peptide isolated from the skin of the African Clawed Frog. Its novel mechanism of action kills microbial targets by disrupting the bacterial cell membrane a process known as cell membrane permeability.